Multi-Industry Plant Setup
End-to-end plant design across Pharmaceutical, Medical Device, IVD, Biological, Cosmetic, Food and Nutraceutical facilities.
For Pharmaceutical, Medical Device, IVD, Biological, Cosmetic, Food and Nutraceuticals.
Trusted by India's Regulated Industries
With Revised Schedule M, evolving CDSCO, FSSAI, and Medical Device Rules, growing export requirements, and stringent global inspections, manufacturing plant setup today demands more than engineering. It requires integrated expertise across facility design, regulatory compliance, quality systems, and operational readiness.
From project planning and engineering to regulatory approvals, validation, certification, and lifecycle compliance, CliniExperts provides every service required to establish and operate a fully compliant manufacturing facility. Our integrated approach helps reduce delays, simplify coordination, and accelerate your journey from concept to commercial production.
Assess technical feasibility, regulatory requirements, utilities, project cost, and commercial viability to make informed investment decisions.
CliniExperts brings all capabilities for manufacturing plant setup together under one roof
End-to-end plant design across Pharmaceutical, Medical Device, IVD, Biological, Cosmetic, Food and Nutraceutical facilities.
One partner, one project manager and one integrated team managing engineering, licensing, validation and commissioning.
Hands-on experience with the relevant knowledge of CDSCO, FSSAI, WHO-GMP, Medical Device Rules and global regulatory requirements.
From pre-project planning to renewals, audits, upgrades and expansions, support continues long after commissioning.
End-to-end entry and compliance support for international manufacturers establishing or expanding their plants in India.
Engineering, regulatory and documentation activities run in parallel to reduce timelines without compromising compliance.
Revised Schedule M is Mandatory from
January 2026
From 1 January 2026, all pharmaceutical manufacturers must comply with the Revised Schedule M. Non-compliance can lead to regulatory action, licence suspension and delays in production and supply.
To know more →Certifications that demonstrate our commitment to quality, security and regulatory excellence.